2005 - 2006 Regulation and Analysis of Excitatory Neuronal Cell Death by Protein Transduction Therapy
2002 - 2005 創薬開発基盤
1998 - 2002 生体内酸素適応
Show all
Papers (31):
Ayaka Mitsui, Hidekazu Iioka, Yiwei Ling, Shujiro Okuda, Akira Kurose, Michael Schopperle, Tomoko Kondo, Masakiyo Sakaguchi, Ken Saito, Eisaku Kondo. Pathological and biological significance of the specific glycan, TRA-1-60, on aggressive gastric adenocarcinoma. Laboratory Investigation. 2024. 102073-102073
Toshiya Fujisaki, Ken Saito, Toshiaki Kikuchi, Eisaku Kondo. The prolyl hydroxylase OGFOD1 promotes cancer cell proliferation by regulating the expression of cell cycle regulators. FEBS letters. 2022. 597. 8. 1073-1085
Eisaku Kondo, Hidekazu Iioka, Ken Saito. Tumor-homing peptide and its utility for advanced cancer medicine. Cancer science. 2021. 112. 6. 2118-2125
Ken Saito, Ayaka Mitsui, I Wayan Sumardika, Yusuke Yokoyama, Masakiyo Sakaguchi, Eisaku Kondo. PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1. International journal of oncology. 2021. 58. 6
1998 - 2002 Saitama University Graduate School, Division of Science and Engineering
1996 - 1998 Saitama University
1991 - 1996 Chuo University Faculty of Science and Engineering
Professional career (1):
博士(学術) (埼玉大学)
Work history (9):
2022/04 - 現在 新潟医療福祉大学 医療技術部 臨床技術学科 教授
2015/09 - 2022/03 Niigata University Graduate School of Medical and Dental Sciences Molecular and Cellular Medicine Cellular Function Associate Professor
2015/03/01 - 2015/08/31 Niigata University Graduate School of Medical and Dental Sciences Molecular and Cellular Medicine Cellular Function Assistant Professor
2013/04 - 2015/02 Aichi Cancer Center, Research Institute
2010/08 - 2013/03 Aichi Cancer Center, Research Institute
2010/04 - 2010/07 University of the Ryukyus Faculty of Medicine
2005/10 - 2010/03 三菱化学生命科学研究所 脳梗塞研究グループ 特別研究員
2002/12 - 2005/09 第一製薬株式会社 創薬開拓研究所 標的研究グループ・契約研究員
2002/04 - 2002/12 理化学研究所 生体物理化学研究室 協力研究員
Show all
Association Membership(s) (3):
日本がん分子標的治療学会
, THE JAPANESE BIOCHEMICAL SOCIETY
, THE JAPANESE CANCER ASSOCIATION